130 related articles for article (PubMed ID: 10851060)
21. Experimental regulation of STAT gene expression reveals an involvement of STAT5 in interleukin-4-driven cell proliferation.
Friedrich K; Wietek S
Biol Chem; 2001 Feb; 382(2):343-51. PubMed ID: 11308032
[TBL] [Abstract][Full Text] [Related]
22. Differential activation of functionally distinct STAT5 proteins by IL-5 and GM-CSF during eosinophil and neutrophil differentiation from human CD34+ hematopoietic stem cells.
Caldenhoven E; van Dijk TB; Tijmensen A; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP
Stem Cells; 1998; 16(6):397-403. PubMed ID: 9831865
[TBL] [Abstract][Full Text] [Related]
23. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
[TBL] [Abstract][Full Text] [Related]
24. STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation.
McLemore ML; Grewal S; Liu F; Archambault A; Poursine-Laurent J; Haug J; Link DC
Immunity; 2001 Feb; 14(2):193-204. PubMed ID: 11239451
[TBL] [Abstract][Full Text] [Related]
25. Differential STAT5 signaling by ligand-dependent and constitutively active cytokine receptors.
Moucadel V; Constantinescu SN
J Biol Chem; 2005 Apr; 280(14):13364-73. PubMed ID: 15677477
[TBL] [Abstract][Full Text] [Related]
26. Comparative study on the phosphotyrosine motifs of different cytokine receptors involved in STAT5 activation.
May P; Gerhartz C; Heesel B; Welte T; Doppler W; Graeve L; Horn F; Heinrich PC
FEBS Lett; 1996 Sep; 394(2):221-6. PubMed ID: 8843168
[TBL] [Abstract][Full Text] [Related]
27. STAT3 and STAT5B are targets of two different signal pathways activated by hematopoietin receptors and control transcription via separate cytokine response elements.
Lai CF; Ripperger J; Morella KK; Wang Y; Gearing DP; Horseman ND; Campos SP; Fey GH; Baumann H
J Biol Chem; 1995 Oct; 270(40):23254-7. PubMed ID: 7559477
[TBL] [Abstract][Full Text] [Related]
28. Enhanced hematopoietic differentiation of embryonic stem cells conditionally expressing Stat5.
Kyba M; Perlingeiro RC; Hoover RR; Lu CW; Pierce J; Daley GQ
Proc Natl Acad Sci U S A; 2003 Sep; 100 Suppl 1(Suppl 1):11904-10. PubMed ID: 12930895
[TBL] [Abstract][Full Text] [Related]
29. Hematopoietic abnormalities in mice deficient in gp130-mediated STAT signaling.
Jenkins BJ; Quilici C; Roberts AW; Grail D; Dunn AR; Ernst M
Exp Hematol; 2002 Nov; 30(11):1248-56. PubMed ID: 12423677
[TBL] [Abstract][Full Text] [Related]
30. The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis.
Jenkins BJ; Roberts AW; Najdovska M; Grail D; Ernst M
Blood; 2005 May; 105(9):3512-20. PubMed ID: 15650055
[TBL] [Abstract][Full Text] [Related]
31. Cytokine signals through STAT3 promote expression of granulocyte secondary granule proteins in 32D cells.
Wang L; Arcasoy MO; Watowich SS; Forget BG
Exp Hematol; 2005 Mar; 33(3):308-17. PubMed ID: 15730854
[TBL] [Abstract][Full Text] [Related]
32. Requirement of gp130 signaling for the AGM hematopoiesis.
Takizawa M; Nobuhisa I; Igarashi K; Ueno M; Nakashima K; Kitamura T; Taga T
Exp Hematol; 2003 Apr; 31(4):283-9. PubMed ID: 12691915
[TBL] [Abstract][Full Text] [Related]
33. STAT3 is required for the gp130-mediated full activation of the c-myc gene.
Kiuchi N; Nakajima K; Ichiba M; Fukada T; Narimatsu M; Mizuno K; Hibi M; Hirano T
J Exp Med; 1999 Jan; 189(1):63-73. PubMed ID: 9874564
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation.
Brocke-Heidrich K; Kretzschmar AK; Pfeifer G; Henze C; Löffler D; Koczan D; Thiesen HJ; Burger R; Gramatzki M; Horn F
Blood; 2004 Jan; 103(1):242-51. PubMed ID: 12969979
[TBL] [Abstract][Full Text] [Related]
35. Activated Stat related transcription factors in acute leukemia.
Gouilleux-Gruart V; Debierre-Grockiego F; Gouilleux F; Capiod JC; Claisse JF; Delobel J; Prin L
Leuk Lymphoma; 1997 Dec; 28(1-2):83-8. PubMed ID: 9498707
[TBL] [Abstract][Full Text] [Related]
36. Cytokine signaling through Stat3 activates integrins, promotes adhesion, and induces growth arrest in the myeloid cell line 32D.
Wooten DK; Xie X; Bartos D; Busche RA; Longmore GD; Watowich SS
J Biol Chem; 2000 Aug; 275(34):26566-75. PubMed ID: 10858439
[TBL] [Abstract][Full Text] [Related]
37. The G-CSF receptor carboxyl terminus, truncated in AML/SCN, is required for induction of a Stat5 protease activity.
Qiu Y; Zhuang D; MacRae A; Dong F
Leuk Res; 2005 Oct; 29(10):1153-62. PubMed ID: 16111533
[TBL] [Abstract][Full Text] [Related]
38. Stochastic model revisited.
Ogawa M
Int J Hematol; 1999 Jan; 69(1):2-5. PubMed ID: 10641435
[TBL] [Abstract][Full Text] [Related]
39. Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation.
Schuringa JJ; Chung KY; Morrone G; Moore MA
J Exp Med; 2004 Sep; 200(5):623-35. PubMed ID: 15353555
[TBL] [Abstract][Full Text] [Related]
40. Abnormal Stat activation, hematopoietic homeostasis, and innate immunity in c-fes-/- mice.
Hackenmiller R; Kim J; Feldman RA; Simon MC
Immunity; 2000 Sep; 13(3):397-407. PubMed ID: 11021537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
